Specify a stock or a cryptocurrency in the search bar to get a summary
Zhejiang Hisun Pharmaceutical Co Ltd
600267Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China. The company provides active pharmaceutical ingredients and finished dosage form products. It offers products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, liver care, and orthopaedics treatment; and weight loss, anti-viral, anti-TB, animal healthcare, and others. The company also exports its products to approximately 70 countries worldwide. The company was founded in 1956 and is headquartered in Taizhou, China. Address: No. 46, Waisha Road, Taizhou, China, 318000
Analytics
WallStreet Target Price
45.56 CNYP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 600267
Dividend Analytics 600267
Dividend growth over 5 years
240 %Continuous growth
2 yearsPayout Ratio 5 years average
-40 %Dividend History 600267
Stock Valuation 600267
Financials 600267
Results | 2019 | Dynamics |